Assessing Liver Function in Patients with HCC - Episode 7

Key Outcomes Data in Patients With HCC Based on Liver Function

October 25, 2023

Rachna Shroff, MD, MS, FASCO, Arndt Vogel, MD, Amit Singal, MD, MS

Amit Singal, MD, reviews analyses of the HIMALAYA and KEYNOTE-240 trials, focusing on the impact of liver function via ALBI grades on treatment outcomes and safety in patients with hepatocellular carcinoma.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Risk Factors of Hepatocellular Carcinoma (HCC)

EP. 2: Importance of Assessing Liver Function in HCC

EP. 3: Assessing Liver Function in Patients With HCC: The ALBI Score

EP. 4: Assessing Liver Function in Patients With HCC: The Child-Pugh Score

EP. 5: Assessing Liver Function in Patients With HCC: The MELD Score

EP. 6: Updates in First-Line Systemic Therapy for Patients With HCC

Now Viewing

EP. 7: Key Outcomes Data in Patients With HCC Based on Liver Function

EP. 8: Rivoceranib plus Camrelizumab for First-Line Treatment of HCC: Data from CARES-310

EP. 9: The Future of Liver Function Assessments in HCC